Ii R.a. Session

Affiliations

  • at Taysha Gene Therapies Inc. (TSHA), 2023-07-14
  • Director at Chardan Healthcare Acquisition 2 Corp. (CHAQ), 2020-04-27
  • Sr. Vp, Corp Strategy at Avexis Inc. (AVXS), 2018-05-15
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TSHA $12.65 26,008 $329,001.20 9,190,920 2021-11-23 Filing
TSHA $12.12 16,510 $200,101.20 9,164,912 2021-11-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TSHA $0.70 5,344 $3,740.80 8,871,747 2023-07-13 Filing
TSHA $0.71 80,528 $57,029.93 8,877,091 2023-07-12 Filing
TSHA $0.70 18,100 $12,735.16 8,957,619 2023-06-23 Filing
TSHA $0.70 10,508 $7,383.97 8,975,719 2023-06-22 Filing
TSHA $0.70 138,962 $97,634.70 8,986,227 2023-06-21 Filing